2022
DOI: 10.1016/j.biotechadv.2022.107966
|View full text |Cite
|
Sign up to set email alerts
|

Microbial chassis engineering drives heterologous production of complex secondary metabolites

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
25
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(30 citation statements)
references
References 261 publications
0
25
0
Order By: Relevance
“…Secondary metabolites are biologically active compounds synthesized by microorganisms using primary metabolites as precursors, which may be involved in the physiological processes of the bacterium itself and may also provide defense and resistance to external stressful environments ( Liu et al, 2022 ). The most common secondary metabolic gene clusters are type I, II, and III polyketides synthase (PKS) and non-ribosomal peptides synthase (NRPS) ( Medema et al, 2011 ).…”
Section: Resultsmentioning
confidence: 99%
“…Secondary metabolites are biologically active compounds synthesized by microorganisms using primary metabolites as precursors, which may be involved in the physiological processes of the bacterium itself and may also provide defense and resistance to external stressful environments ( Liu et al, 2022 ). The most common secondary metabolic gene clusters are type I, II, and III polyketides synthase (PKS) and non-ribosomal peptides synthase (NRPS) ( Medema et al, 2011 ).…”
Section: Resultsmentioning
confidence: 99%
“…Abundant secondary metabolites indicated that it could provide abundant substrates for expressing heterologous BGCs. In addition to possessing huge biosynthetic potential, strain E264 also has a fast growth rate, which makes it more suitable as a heterologous host ( Mao et al, 2017 ; Liu et al, 2022 ). However, as a member of the genus Burkholderia , the intrinsic multidrug-resistance of the wild-type strain E264 makes genetic manipulation difficult, which partially results from the resistance-nodulation-division family efflux pumps ( Biot et al, 2011 , 2013 ).…”
Section: Introductionmentioning
confidence: 99%
“…During this assembly process, each NRPS has to interact with its upstream and/or downstream NRPS(s) to transfer the monomer substrate or the growing peptidyl chain intermediates. Previous studies have reported the use of heterologous hosts (e.g., Escherichia coli , yeast, and Streptomyces ) to produce NRPs by recombinant coexpression of the related NRPS enzymes (Li & Neubauer, 2014; J. Liu, Wang, et al, 2022; Tippelt & Nett, 2021; Zhang et al, 2022). However, these product yields are often low even after a series of systematic optimizations, for instance, strain engineering, precursor feeding, and high cell density cultivation.…”
Section: Introductionmentioning
confidence: 99%